PB2338 LONG‐TERM OUTCOMES OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN SEVERE APLASTIC ANEMIA: PNH CLONES MATTER
Ioanna Sakellari(G. Papanikolaou General Hospital), Αchilles Anagnostopoulos(G. Papanikolaou General Hospital), Eleni Gavriilaki(Aristotle University of Thessaloniki), Varnavas Constantinou(G. Papanikolaou General Hospital), Marianna Masmanidou(G. Papanikolaou General Hospital), Vassiliki Douka(G. Papanikolaou General Hospital), Antonia Syrigou(G. Papanikolaou General Hospital), Ioannis Batsis(G. Papanikolaou General Hospital), Thomas Chatzikonstantinou(G. Papanikolaou General Hospital), Anna Vardi(G. Papanikolaou General Hospital), Damianos Sotiropoulos(G. Papanikolaou General Hospital), Zoi Bousiou(G. Papanikolaou General Hospital), D. Mallouri(G. Papanikolaou General Hospital), Christos Demosthenous(G. Papanikolaou General Hospital)
Cited by 0
Related Papers
Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients
|Blood|2020|657
Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases
|Blood|2011|178
COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study
|Leukemia|2021|94
Immunogenetics shows that not all MBL are equal: the larger the clone, the more similar to CLL
|Blood|2013|93
Genetic prediction of ICU hospitalization and mortality in COVID‐19 patients using artificial neural networks
|Journal of Cellular and Molecular Medicine|2022|90